Nuvation Bio

$11.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-3.49%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Nuvation Bio and other stocks, options, and ETFs commission-free!

About NUVB

Nuvation Bio Inc., also called Nuvation Bio, is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

CEO
David T. Hung
Employees
—
Headquarters
New York, New York
Founded
2018
Market Cap
2.25B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
919.82K
High Today
$11.89
Low Today
$11.28
Open Price
$11.64
Volume
231.70K
52 Week High
$15.08
52 Week Low
$8.56

NUVB Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

RC-C
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure